[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 9445 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 9445

 To direct the Secretary of Defense to replace certain syringes of the 
                         Department of Defense.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            August 30, 2024

 Ms. Sherrill introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL


 
 To direct the Secretary of Defense to replace certain syringes of the 
                         Department of Defense.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Safe Military Medical Equipment 
Act''.

SEC. 2. PLAN FOR IDENTIFYING AND REPLACING SYRINGES OF CONCERN.

    (a) In General.--Not later than 180 days after the date of the 
enactment of this Act, the Secretary of Defense, in coordination with 
the Director of the Defense Logistics Agency and the Director of the 
Defense Health Agency, shall develop and implement a plan to review all 
medical syringes in the inventories and stockpiles of the Department of 
Defense and current and planned acquisitions of the Department to--
            (1) identify medical syringes that have been subject to a 
        Food and Drug Administration Import Alert or meet the 
        conditions of a Food and Drug Administration Safety 
        Communication; and
            (2) replace such medical syringes with medical syringes 
        produced domestically or produced in partners or allies of the 
        United States.
    (b) Coordinated Plan Contents.--The Secretary of Defense shall 
include in the plan required under subsection (a) the following:
            (1) An identification of any medical syringes in the 
        inventories and stockpiles of the Department of Defense and 
        which the Department is acquiring or plans to acquire that have 
        been subject to a Food and Drug Administration Import Alert or 
        meet the conditions of a Food and Drug Administration Safety 
        Communication made in the past five years.
            (2) A process for the Department of Defense to replace the 
        medical syringes described in paragraph (1) that are in the 
        inventories and stockpiles of the Department with those that--
                    (A) are produced domestically or in partners or 
                allies of the United States;
                    (B) are not subject to an Import Alert described in 
                such paragraph; and
                    (C) do not meet the conditions of a Safety 
                Communication described in such paragraph.
            (3) A process for the Department of Defense to cease the 
        acquisition of medical syringes described in paragraph (1) and 
        ensure that the Department acquires only medical syringes 
        that--
                    (A) are produced domestically or in partners or 
                allies of the United States;
                    (B) are not subject to an Import Alert described in 
                such paragraph; and
                    (C) do not meet the conditions of a Safety 
                Communication described in such paragraph.
            (4) A process enabling the Department of Defense to--
                    (A) track Food and Drug Administration Import 
                Alerts and Safety Communications regarding medical 
                syringes;
                    (B) review the inventories, stockpiles, and current 
                and planned acquisitions of the Department for medical 
                syringes that are subject to such Import Alerts or that 
                meet the conditions of such Safety Communications; and
                    (C) replace such medical syringes with medical 
                syringes that are produced domestically or produced in 
                partners or allies of the United States.
    (c) Report.--Upon developing the plan required by subsection (a), 
the Secretary of Defense shall submit to the Committees on Armed 
Services of the Senate and the House of Representatives a report 
describing such plan, including--
            (1) the number of medical syringes, if any, in the 
        inventories and stockpiles of the Department of Defense that 
        have been subject to a Food and Drug Administration Import 
        Alert or meet the conditions of a Food and Drug Administration 
        Safety Communication made in the past five years;
            (2) a description of any planned or ongoing acquisition by 
        the Department of medical syringes that have been subject to a 
        Food and Drug Administration Import Alert or meet the 
        conditions of a Food and Drug Administration Safety 
        Communication made in the past five years, including 
        acquisitions with respect to which contracts have not yet been 
        awarded and existing agreements under which such syringes may 
        be acquired for the Department;
            (3) for medical syringes described in paragraph (1) or with 
        respect to which the Department is carrying out an acquisition 
        described in paragraph (2), the product name, manufacturer, and 
        country of origin; and
            (4) an explanation of the process described in subsection 
        (b)(4) that will be implemented under such plan.
                                 <all>